Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Background/Aims: Aspirin has been demonstrated to possess potent chemopreventive and anticancer effects on prostate cancer. However, the more detailed molecular mechanisms of aspirin to suppress prostate cancer cell invasion have not been clearly elucidated. Methods: Transwell assays were performed...

書誌詳細
主要な著者:	Chongjun Shi, Nini Zhang, Yang Feng, Jiewei Cao, Xuyi Chen, Bin Liu
フォーマット:	論文
言語:	English
出版事項:	Cell Physiol Biochem Press GmbH & Co KG 2017-03-01
シリーズ:	Cellular Physiology and Biochemistry
主題:	Invasion Matrix metalloproteinase Nuclear factor-kappa B Prostate cancer Urokinase-type plasminogen activator
オンライン･アクセス:	http://www.karger.com/Article/FullText/464434

類似資料

Inhibitory effects of wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen activator
著者:: Yung-Chuan Ho, 等
出版事項: (2014-06-01)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
著者:: Shirin Kouhpayeh, 等
出版事項: (2017-01-01)

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach
著者:: Benjamin Talbot, 等
出版事項: (2020-05-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
著者:: Koh, Angela S., 等
出版事項: (2018)

Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients
著者:: Sofia C. Ramos, 等
出版事項: (2017-08-01)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
著者:: Lampelj Maja, 等
出版事項: (2015-12-01)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
著者:: Manuel Yepes
出版事項: (2020-01-01)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
著者:: Shengyuan Luo, 等
出版事項: (2022-09-01)

Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge
著者:: Krzysztof Kowal,, 等
出版事項: (2010-04-01)

Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High‐Sensitivity C‐Reactive Protein
著者:: Salim S. Hayek, 等
出版事項: (2018-05-01)

The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
著者:: Ashna A. Kumar, 等
出版事項: (2022-01-01)

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma
著者:: Elahe Minaei, 等
出版事項: (2022-04-01)

QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
著者:: Rahul D. Jawarkar, 等
出版事項: (2024-06-01)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
著者:: Nergiz Erkut, 等
出版事項: (2016-05-01)

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
著者:: Tetiana Yatsenko, 等
出版事項: (2024-01-01)

Urokinase-type plasminogen activator (uPA) regulates invasion and matrix remodelling in colorectal cancer
著者:: Auxtine Micalet, 等
出版事項: (2023-12-01)

Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
著者:: Tetiana Yatsenko, 等
出版事項: (2024-03-01)

Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
著者:: Ioannis Griveas, 等
出版事項: (2021-07-01)

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
著者:: Dženita Ljuca, 等
出版事項: (2007-05-01)

Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis
著者:: LI Yang, 等
出版事項: (2022-02-01)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
著者:: Noboru Ichihara, 等
出版事項: (2017-10-01)

Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor‐1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
著者:: Michel T. Corban, 等
出版事項: (2018-08-01)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
著者:: Ran Zhu, 等
出版事項: (2022-08-01)

Can serum soluble urokinase plasminogen activator receptor be an effective biomarker in comparing the inflammatory response between laparoscopic and open appendectomy?
著者:: Basak Erginel, 等
出版事項: (2023-06-01)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
著者:: Branko Brdar, 等
出版事項: (2002-01-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
著者:: T. Grinenko, 等
出版事項: (2019-12-01)

The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix
著者:: Hatoum A, 等
出版事項: (2019-02-01)

Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator
著者:: Mostafa Hamada, 等
出版事項: (2024-05-01)

The Urokinase-Type Plasminogen Activator Contributes to cAMP-Induced Steroidogenesis in MA-10 Leydig Cells
著者:: Zoheir B. Demmouche, 等
出版事項: (2022-07-01)

Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia
著者:: Yuqian Li, 等
出版事項: (2017-08-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
著者:: Niaz Mahmood, 等
出版事項: (2018-02-01)

Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis
著者:: Ery Olivianto, 等
出版事項: (2019-01-01)

Febrile phase soluble urokinase plasminogen activator receptor and olfactomedin 4 as prognostic biomarkers for severe dengue in adults
著者:: Teo, Andrew, 等
出版事項: (2024)

Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury
著者:: Wenwen Zhang, 等
出版事項: (2024-12-01)

Soluble urokinase-type plasminogen activator receptor as a biomarker for focal segmental glomerulosclerosis; a retrospective analysis
著者:: Miguel Verdelho, 等
出版事項: (2018-07-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
著者:: YANTI
出版事項: (2010-03-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
著者:: YANTI
出版事項: (2010-03-01)

Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia
著者:: Muhammad Said El-Mekkawy, 等
出版事項: (2022-02-01)

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Incident Heart Failure Risk
著者:: Adithya K. Yadalam, MD, MSc, 等
出版事項: (2025-01-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
著者:: Angela S. Koh, 等
出版事項: (2017-11-01)